Smaller venture deals pick up going into SVB crisis
AW Research tracked about $2.3 billion in private market deals across credit, equity, infrastructure and real ...
Read more
Life Sciences
Large PE deals in the spotlight
AW Research tracked about $15.5 billion in private market deals across credit, equity, infrastructure and real estate ...
Read more
PE flocks to early-stage deals
AW Research tracked about $1 billion in private market deals across credit, equity, infrastructure and real estate ...
Read more
Early round fintech, health tech deals dominate
Divided by asset class, Alternatives Watch tracked a total of roughly $2.1 billion in deals publicly announced in ...
Read more
NEA raises $6.2bn across two tech and healthcare funds
New Enterprise Associates (NEA) closed two funds with $6.2 billion - its largest pool of capital ...
Read more
Patient Square hires head of MENA, international fund partnerships
Healthcare-focused private equity firm Patient Square Capital hired Kaveh Samie as partner, MENA chairman and CEO ...
Read more
Biotech activity dominates as private markets embrace healthcare
Divided by asset class, Alternatives Watch tracked a total of roughly $1.8 billion in deals publicly announced in ...
Read more
Healthcare hedge fund Rhenman suffers rare annual loss
Healthcare-focused hedge fund Rhenman & Partners Asset Management has suffered a rare down year following 2022’s ...
Read more
Catalio Capital taps into life sciences with equity hedge fund launch
Catalio Capital Management unveiled a global long/short equity hedge fund strategy targeting key opportunities across the ...
Read more
Credit deals lead the way in final weeks of 2022
Divided by asset class, Alternatives Watch tracked a total of roughly $5 billion in deals publicly announced for ...
Read more
© 2019-2022, All Rights Reserved | BMV Digital
